BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20694805)

  • 1. Effectiveness of thrombolysis in patients with intermediate-risk pulmonary embolism: influence on length of hospital stay.
    Berghaus TM; Thilo C; Bluethgen A; von Scheidt W; Schwaiblmair M
    Adv Ther; 2010 Sep; 27(9):648-54. PubMed ID: 20694805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-accelerated thrombolysis (USAT) versus standard catheter-directed thrombolysis (CDT) for treatment of pulmonary embolism: A retrospective analysis.
    Rothschild DP; Goldstein JA; Ciacci J; Bowers TR
    Vasc Med; 2019 Jun; 24(3):234-240. PubMed ID: 30915912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective comparison of ultrasound facilitated catheter-directed thrombolysis and systemically administered half-dose thrombolysis in treatment of pulmonary embolism.
    Sharifi M; Awdisho A; Schroeder B; Jiménez J; Iyer P; Bay C
    Vasc Med; 2019 Apr; 24(2):103-109. PubMed ID: 30834822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.
    Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Accelerated, Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism: Single-Center Retrospective Review with Intermediate-Term Outcomes.
    Makary MS; Fogler BD; Dube PP; Flanders VL; Natarajan K; Garcia-Cortes R; Foster T; Dowell JD
    J Vasc Interv Radiol; 2020 Mar; 31(3):438-443. PubMed ID: 31982316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced dose thrombolysis with ultrasound-facilitated catheter-directed administration for acute pulmonary embolism reduces length of stay.
    Wayne NB; Davis GA; Macaulay TE; Beavers CJ; Messerli AW; Dugan A; Smyth SS
    J Thromb Thrombolysis; 2020 May; 49(4):540-544. PubMed ID: 31797241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of flow-directed pulmonary artery catheter thrombolysis for treatment of submassive pulmonary embolism.
    Gaba RC; Gundavaram MS; Parvinian A; Knuttinen MG; Minocha J; Owens CA; Bui JT
    AJR Am J Roentgenol; 2014 Jun; 202(6):1355-60. PubMed ID: 24848835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Fibrinogen Levels during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
    Graif A; Grilli CJ; Kimbiris G; Paik HH; Leung DA
    J Vasc Interv Radiol; 2020 Aug; 31(8):1281-1289. PubMed ID: 32703545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-Day ICU Discharge in Selected Patients With Severe Submassive Pulmonary Embolism Treated With Catheter-Directed Thrombolysis.
    Das Gupta J; Marek J; Rana MA; Guliani S
    Vasc Endovascular Surg; 2020 Jan; 54(1):58-64. PubMed ID: 31500542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study.
    Curtis GM; Lam SW; Reddy AJ; Bauer SR
    Pharmacotherapy; 2014 Aug; 34(8):818-25. PubMed ID: 24854996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
    Graif A; Kimbiris G; Grilli CJ; Agriantonis DJ; Putnam SG; Leung DA
    J Vasc Interv Radiol; 2020 Apr; 31(4):537-543. PubMed ID: 31959518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge.
    Sharifi M; Bay C; Schwartz F; Skrocki L
    Clin Cardiol; 2014 Feb; 37(2):78-82. PubMed ID: 24122947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic thrombolysis in pulmonary embolism - another paradigm falling?
    Freisinger E; Reinecke H
    Vasa; 2015 Mar; 44(2):156. PubMed ID: 25698395
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.
    Bagla S; Smirniotopoulos JB; van Breda A; Sheridan MJ; Sterling KM
    J Vasc Interv Radiol; 2015 Jul; 26(7):1001-6. PubMed ID: 25704224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
    Mele M; Mele A; La Torre PP; Cannone M
    G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-assisted thrombolysis in submassive and massive pulmonary embolism: assessment of lung obstruction before and after catheter-directed therapy.
    Quintana D; Salsamendi J; Fourzali R; Narayanan G
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):420-6. PubMed ID: 23860937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
    Avgerinos ED; Saadeddin Z; Abou Ali AN; Fish L; Toma C; Chaer M; Rivera-Lebron BN; Chaer RA
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):530-540. PubMed ID: 29909859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.
    Tapson VF; Sterling K; Jones N; Elder M; Tripathy U; Brower J; Maholic RL; Ross CB; Natarajan K; Fong P; Greenspon L; Tamaddon H; Piracha AR; Engelhardt T; Katopodis J; Marques V; Sharp ASP; Piazza G; Goldhaber SZ
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1401-1410. PubMed ID: 30025734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.